Ikervis for DED Due to GVHD Post Allo-HSCT
NCT04636918
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Leukemia (Both ALL and AML)
MDS-EB-1
Interventions
DRUG:
Cyclosporine Ophthalmic
Sponsor
Singapore Eye Research Institute